• STAT Plus: FDA shuffles longtime division head, Janet Woodcock, to focus exclusively on Covid-19 vaccine project

    11 days ago - By STAT

    WASHINGTON - Food and Drug Administration stalwart Janet Woodcock will temporarily step aside as the director of the agency's Center for Drug Evaluation and Research to work solely on a White House initiative meant to accelerate Covid-19 treatments, Commissioner Stephen Hahn announced Friday in an agency-wide email obtained by STAT.
    The news is monumental for the FDA: Woodcock has served as the permanent director of CDER for more than a decade, since 2008. She joined the FDA in 1986 and is widely considered the most experienced regulator at the agency. Her cache has often rivaled that of...
    Read more ...

     

  • First generic version of Gilead's remdesivir will be sold by a Bangladesh drug maker

    11 days ago - By STAT

    A drug maker in Bangladesh has become the first company to sell a generic version of remdesivir, the latest sign of how the push to ensure widespread access to Covid-19 medicines and vaccines has become an urgent issue in poor countries.
    Following an emergency decree issued by the Bangladesh government, Beximco Pharmaceuticals is donating copies of the Gilead Sciences medicine to state-run hospitals free of charge, but will also sell the intravenous treatment to private clinics. Moreover, the company is reportedly willing to export its version if other governments request the drug...
    Read more ...

     

  • Disruption to global immunization system could delay COVID-19 vaccinations

    11 days ago - By Reuters

    Massive disruptions to global immunisation programmes from the COVID-19 pandemic have health experts fearful that much of the developing world will not be able to get a vaccine for the new coronavirus, even once one is ready.
    Read more ...

     

  • CanSino beats Moderna again, this time to peer-reviewed, published Covid-19 vaccine data

    CanSino beats Moderna again, this time to peer-reviewed, published Covid-19 vaccine data

    11 days ago - By MedCity News

    The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released preliminary data this week, but it was seen as too early for interpreting its vaccine's efficacy.
    Read more ...

     

  • South America is a new COVID 'epicentre', African deaths still low: WHO

    11 days ago - By Reuters

    South America has become a new epicentre of the COVID-19 pandemic with Brazil hardest-hit, while cases are rising in some African countries that so far have a relatively low death toll, the World Health Organization said on Friday.
    Read more ...

     

  • How one Indian company could be world's door to a COVID-19 vaccine

    11 days ago - By Reuters

    If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India.
    Read more ...